These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1101047)

  • 1. Relationship between acetylator status and response to phenelzine.
    Johnstone EC
    Mod Probl Pharmacopsychiatry; 1975; 10():30-7. PubMed ID: 1101047
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylator status and response to phenelzine in depressed patients.
    Johnstone EC; Marsh W
    Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between response to phenelzine and acetylator status in depressed patients.
    Johnstone EC; Marsh W
    Proc R Soc Med; 1973 Sep; 66(9):947-9. PubMed ID: 4616245
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.
    Marshall EF; Mountjoy CQ; Campbell IC; Garside RF; Leitch IM; Roth M
    Br J Clin Pharmacol; 1978 Sep; 6(3):247-54. PubMed ID: 356868
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Phenelzine and acetylator status.
    Carr A
    Lancet; 1974 Aug; 2(7877):412. PubMed ID: 4136972
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
    Davidson J; McLeod MN; Blum MR
    Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.
    Johnstone EC
    Psychopharmacologia; 1976 Apr; 46(3):289-94. PubMed ID: 951464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator status and response to phenelzine.
    Tilstone WJ; Johnstone EC
    Lancet; 1978 Nov; 2(8100):1151-2. PubMed ID: 82710
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of acetylator phenotype on antidepressant effects of phenelzine.
    Paykel ES; West PS; Rowan PR; Parker RR
    Br J Psychiatry; 1982 Sep; 141():243-8. PubMed ID: 6753997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenelzine: acetylator status and clinical response.
    Sanders GL; Rawlins MD
    Br J Clin Pharmacol; 1979 May; 7(5):451-2. PubMed ID: 475942
    [No Abstract]   [Full Text] [Related]  

  • 12. Age-sex differences in response to antidepressant drugs.
    Raskin A
    J Nerv Ment Dis; 1974 Aug; 159(2):120-30. PubMed ID: 4850465
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylator status and inhibition of platelet monoamine oxidase following treatment with phenelzine.
    Yates CM; Loudon JB
    Psychol Med; 1979 Nov; 9(4):777-9. PubMed ID: 515276
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylator phenotype in relation to monoamine oxidase inhibitor antidepressant drug therapy.
    Whitford GM
    Int Pharmacopsychiatry; 1978; 13(2):126-32. PubMed ID: 352977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
    Mountjoy CQ; Roth M; Garside RF; Leitch IM
    Br J Psychiatry; 1977 Nov; 131():486-92. PubMed ID: 338081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pharmacokinetic factors affecting response to phenelzine.
    Tyrer P; Gardner M; Lambourn J; Whitford M
    Br J Psychiatry; 1980 Apr; 136():359-65. PubMed ID: 6992903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenelzine and acetylator phenotype.
    Rowan PR; Paykel ES; West PS; Rao BM; Taylor CN
    Neuropharmacology; 1981 Dec; 20(12B):1353-4. PubMed ID: 7322308
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of phenelzine and amitriptyline: a placebo controlled trial.
    Rowan P; Paykel ES; Parker PR; West E
    Neuropharmacology; 1980 Dec; 19(12):1223-5. PubMed ID: 7003429
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression.
    Davidson J; McLeod M; Law-Yone B; Linnoila M
    Arch Gen Psychiatry; 1978 May; 35(5):639-42. PubMed ID: 727903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.
    Raskin A; Crook TH
    Psychol Med; 1976 Feb; 6(1):59-70. PubMed ID: 935298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.